Hypoxia-alleviated sonodynamic therapy based on a hybrid protein oxygen carrier to enhance tumor inhibition-Reference-Cited by-同舟云学术

Hypoxia-alleviated sonodynamic therapy based on a hybrid protein oxygen carrier to enhance tumor inhibition

Published:2022 Issue:1 Volume:10 Page:294-305
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Yin Ting¹²,Yin Jia²,Ran Hui¹²,Ren Yaguang²,Lu Chengyu¹,Liu Lanlan²,Shi Qingxia¹²,Qiu Yuzhi¹,Pan Hong²,Ma Aiqing¹²^ORCID

Affiliation:

1. Guangdong Key Laboratory for Research and Development of Natural Drugs, Key Laboratory for Nanomedicine, Guangdong Medical University, Dongguan 523808, PR China

2. Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences, Shenzhen 518055, P.R. China

Abstract

Sonodynamic therapy (SDT) is a highly attractive therapy due to its advantages of being non-invasive and having good penetration depth, but tumor hypoxia extremely restricts its therapeutic effect.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/BM/D1BM01710A

Reference42 articles.

1. Gold nanocages covered by smart polymers for controlled release with near-infrared light

2. Nanotechnology for Multimodal Synergistic Cancer Therapy